Herpes Simplex VirusesTherapeutics Flashcards

1
Q

Etiology

A

HSV type 1
– Commonly termed cold
sores or fever blisters
– Typically associated with
oral lesions (herpes
labialis)
* HSV type 2
– Also known as herpes
genitalia
– Predominantly
associated with genital
lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Transmission

A
  • Requires close contact with someone who is shedding the
    virus
    – can occur during active outbreak or when asymptomatic
  • Inoculation of virus onto susceptible mucosal surfaces (e.g.
    oropharynx, cervix, conjunctivae) or through small cracks in
    skin
  • HSV-1: commonly transmitted through oral-to-oral contact
    (virus in saliva, sores, and surfaces in and around the mouth)
  • HSV-2: commonly transmitted via sexual activity (oral-genital,
    genital-genital)
  • Mother-to-infant transmission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Viral Shedding –Herpes Labialis

A
  • Cold sores contagious from prodrome until lesion
    completed healed
    – most contagious when blister bursts or leaks fluid
  • Viral titer greater when lesions present but
    asymptomatic transmission possible
    – one study found at least 70% of the population shed
    HSV-1 asymptomatically at least once a month
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Viral Shedding – Genital Herpes

A

Up to 70% of new infections attributed to
asymptomatic viral shedding
* Asymptomatic shedding occurs in virtually all
patients with HSV-2
* 50% of viral shedding occurs more than 7 days
before or after a clinical outbreak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology of HSV infections

A
  • Two phases of infection:
    – Primary (initial)
    – Secondary (recurrent)
  • Initial infection:
    – HSV replicates in cells of epithelium and infects nerve
    ending
    – Transported to nerve (craniospinal) ganglia – latent
    infection
  • Trigeminal ganglia (HSV-1) and sacral ganglia (HSV-2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology

recurrence and factors that trigger it

A
  • Recurrence:
    – viral replication reactivated in ganglion
    – spreads to mucosal surfaces through peripheral sensory nerves
  • Factors which may trigger recurrence:
    – HSV-1: psychological stress, fatigue, viral illness (e.g., cold or
    influenza), exposure to UV light, local skin trauma, dental treatment,
    menstruation, immune suppression
    – HSV-2: psychological stress, menstruation, local friction, surgery,
    immune suppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HSV and immune response

A
  • HSV-1 and HSV-2 infection induce cell mediated
    immunity and production of antibodies
    – Immune mechanisms modify severity of clinical recurrence
    and reduce HSV replication once reactivation occurs
    – Immune suppressed – ↑ risk for severe herpes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

slide 12

A

ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Signs and Symptoms – Primary Infection
Gingivostomatitis

A

– Most primary infections are subclinical
– infection determined later through serology or recurrence
– many never have recurrence
– Symptomatic - multiple painful vesicles/blisters and
ulcerative erosions involving lips, oral cavity, pharynx, and
perioral skin
– may also experience systemic symptoms - malaise, fever, muscle
aches, lymphadenopathy
– most common in children
– Healing: days to 2-3 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Signs and Symptoms – Primary Infection
Genital Herpes

A

– Papules and vesicles on the groin, pubic and genital areas,
anus, rectum or buttocks that can rupture and lead to painful
ulcers before healing
– HSV-2 is more severe than HSV-1, and may include systemic
symptoms (40% symptomatic)
– Incubation: ~6 days
– Lesions: 11-12 days
– Symptoms: severe burning pain, itching, dysuria, and vaginal
or urethral discharge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Signs and Symptoms- Recurrence

oral lesions

A

Prodromal period described as tingling, discomfort, burning or itching
may occur 2-24 hours before the appearance of the vesicle in the
location of the eruption

Oral lesions (Cold Sores)
● 20-40% of young adults
seropositive for HSV-1 have
recurrent herpes labialis (typically
2-3 times per year)
● Clusters of small vesicles appear
on a reddened (in some skin tones)
base. Range from 0.5 -1.5 cm
● Vesicles typically last ~ a few days
before they rupture and dry out
● Can also appear in the nose or
eyes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Signs and Symptoms- Recurrence
Genital Lesions

A

● Frequency and severity varies
○ 90% of people with
symptomatic primary HSV-2
experience reactivation
○ Can occur every 2-3 weeks to
every 4-6 months
● Less severe and shorter duration
than primary episode
● May also experience prodrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Visual staging chart for Herpes Simplex Labialis progression.

Diagnosis of herpes labialis

A

ok

Diagnosis based on presence of typical signs and
symptoms
– need to rule out other conditions with similar
signs/symptoms (see differential assessments)
* If uncertainty, HSV best confirmed by HSV PCR swab
of lesion (or culture)
* Serology tests typically not used for diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Assessment of Cold Sores

A

Symptoms- Prodrome? Pain? Redness? Visible lesion?
Characteristics- burning, tingling, itching
History- Primary infection? Already diagnosed? How often are
recurrences?
Onset- Prodrome usually 2-24 hrs before lesion appearance (sooner for
most)
Location- Not always on lips, can appear on skin elsewhere
Aggravating Factors- identifiable triggers?
Remitting Factors- used anything helpful before?
Don’t forget to consider…
Medications
Allergies
Conditions
Social history
(also Pregnancy & breastfeeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Differential Assessment

A
  • Recurrent aphthous stomatitis (canker sores)
  • Chicken pox
  • Shingles (Herpes zoster)
  • Oral cancers (basal cell carcinoma)
  • Angular cheilitis
  • Impetigo
  • Syphilis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When to refer patients with cold
sores for further evaluation?

A
  • Age <12 years
  • Lesion present for > 14 days
  • Lesion appears infected -excessively swollen, red or contain
    pus
  • Symptoms of systemic illness (fever, swollen glands)
  • Compromised immune system due to medication or disease
    state
  • Frequent recurrences - > 6 times per year
17
Q

Assessment – Case Study
* Katie is a 21 year-old female (pronouns: she/her)
* History – tingling started 2 days ago and lesion broke out ~36 hours ago;
has noticed dry lips lately; finds lesion is somewhat painful but more
worried about appearance – feels self-conscious
* PMH: no other medical conditions; previous cold sores – occur ~ once or
twice a year; typically related to stress or sunlight; currently stressed as
she needs to find a job
* Medications: has tried Blistex® lip ointment in the past– does not find it
effective; only taking birth control pill. Would prefer to take a pill to treat
cold sore.
* NKDA
* Non-smoker, social drinker; single (does not have steady partner)

A

ok

18
Q

Goals of Therapy

A

primary and recurrent episodes:
– control severity and duration of symptoms
* goal of suppressive therapy:
– reduce recurrences, frequency and extent of viral
shedding, and decrease disease transmission

19
Q

What to recommend???
What is the evidence???

A
  • Analgesics
  • Non-antiviral topical agents
  • Antiviral agents
    – Topical
    – Oral
20
Q

Approaches to Treatment: Herpes
Labialis

A
  • Intermittent Episodic Therapy
    – Management of isolated acute episodes
    – Topical or oral therapy can be used
  • Chronic Suppressive Therapy
    – Appropriate for patients who are psychologically distressed
    (frequent episodes or severe disease)
    – May be used to decrease transmission to uninfected partners
    – Oral therapy only
  • Intermittent Suppressive Therapy
    – Used when recurrences can be anticipated (e.g. known
    precipitating factors)
21
Q

Analgesics

A
  • Oral analgesics
  • recommended for moderate-severe pain (e.g., < 3 days)
  • acetaminophen, ibuprofen, naproxen
  • Topical anesthetics
  • useful for mild pain and relatively short time period
  • Benzocaine (e.g., Anbesol, Orajel, Zilactin-B)
  • Camphor/menthol/phenol (Blistex)
  • Lidocaine
  • Pramoxine (Gold Bond Medicated anti-itch, Polysporin itch
    relief)
22
Q

Non-antiviral topical agents

A

Type of Products:
– Protectants: (e.g. petrolatum, zinc oxide, cocoa butter, allantoin or
calamine)
– prevent cracking and excess drying of lips and lesion
– Astringents (e.g. tannic acid)
– not recommended due to excessive drying – lead to cracking,
fissuring, possible bacterial superinfection

Active Ingredient Examples:
○ Zinc (Lipactin®️)– MOA controversial, may prevent virus attachment
to cells; not well studied. Known to be irritating, may be drying.
○ Heparin (also in Lipactin®️) – reduces binding of virus to cellular
target in cell lines tested in lab; no published evidence regarding
safety and efficacy
○ Benzyl Alcohol (Zilactin®️)- similar to a topical anesthetic for pain,
note alcohol is drying

23
Q

ColdSore-Fx®

A
  • Ingredients: 3% Propolis ACF
    – non-medicinal: white petrolatum, mineral
    oil, lanolin, and ethanol
  • Propolis is a resinous substance bees collect
    from variety of plant sources
  • Dose: apply topically 4-6 times daily until
    healed
  • ‘Possibly effective’ for herpes labialis
  • Might reduce cold sore duration and
    reduce pain compared to placebo
24
Q

Lysine

A
  • Lysine supplementation not shown to prevent herpes simplex
    infections based on Cochrane review
  • “Possibly effective” for herpes labialis at 1-3 g daily (Natural
    Medicines)
  • Evidence is mixed
  • Another evidence review:
    – Doses < 1 g/day - ineffective for prophylaxis or treatment
    – Doses > 3 g/day - appear to improve subjective experience of the
    disease
25
Q

Oro-labial herpes - Topical Antiviral

A

Acyclovir 5% cream + hydrocortisone 1% (Xerese®)
Apply 5 times daily for 5 days.
Start during prodrome(earliest sign).
~0.5 day ~ 0.5 day
Acyclovir ointment not as
effective as cream.
Xerese® - prescription
May decrease progression of lesions.
Topical slightly less effective than oral.

Docosanol 10% cream
(Abreva®) Apply 5 times a day until healed (5-10 days). Start during prodrome (earliest sign).
~ 0.5-1 day ~ 0.5 day Over the counter (cost - ~$18-$25)
May help abort attacks.
Topical slightly less effective than oral

26
Q

Oral-Labial HSV - Immunocompetent
* Primary Infections

A

– Moderate to severe cases – antiviral treatment often
recommended
– Most effective when initiated promptly
– Evidence available suggests significantly decreased disease
duration and period of infectivity in children (duration of
lesions 4 days with acyclovir versus 10 days with placebo)
– Acyclovir 15 mg/kg (up to 200 mg) 5 times a day x 7 days
– Valacyclovir 1 g twice a day x 7 days
– Famciclovir 500 mg twice a day x 7 days

27
Q

Oral-Labial HSV – Immunocompetent
Recurrent (Intermittent Episodic Therapy)

A

Acyclovir 400 mg 5 times daily for 5 days
(start during prodrome phase)
~ 1 day ~ 0.5-1 day Helps abort lesions.
Ineffective if started once lesions appear.

Valacyclovir 2000 mg very 12 hours x 2 doses
(start during prodrome phase)
~1-2 days ~ 0.5-1 day Helps abort lesions.
Ineffective if started once lesions appear.

Famciclovir 750 mg every 12 hours x 2
doses or 1500 mg once (start during prodrome phase)
~1-2 days ~ 0.5-1 day Helps abort lesions.
Ineffective if started once lesions appear

28
Q

Oro-Labial HSV –Chronic Suppressive
Therapy
* Consider for patients with severe disease and frequent
recurrences (e.g. > 6/year)

A

Acyclovir 400 mg twice daily
~50% Clinical benefit is small.
Effectiveness beyond 4
months is unknown.

Valacyclovir 500 mg once daily
Decrease of 0.09 episodes per person per month.
Clinical benefit is small. Effectiveness beyond 4 months is unknown.

29
Q

Oro-Labial HSV – Intermittent
Suppressive Therapy

A
  • Used when outbreaks can be anticipated (e.g.
    exposure to UV light, skiers)
  • Limited studies support use of oral antiviral therapy
    – may not impact lesions that develop within 48
    hours of UV exposure
  • Optimal dose and preferred antiviral agent unknown
  • Suggested dose:
  • acyclovir 400 mg twice daily starting 12-24 hours before
    exposure and continuing through intense exposure (plus
    sunscreen)
30
Q

Options in Pregnancy

A

Oral:
* Acyclovir: human & animal data have shown it is
safe in all stages of pregnancy (most data is for
genital herpes)
* Valacyclovir: less data on safety in pregnancy but is
considered an alternative to acyclovir
* Famciclovir: limited pregnancy data in humans
Topical:
* Docosanol: likely safe but limited data in pregnancy
* Topical Acyclovir: considered safe (same as oral)

31
Q

Counselling Tips

A

Immediate lesion
– Prevention of transmission – wash hands, do not touch
area, do not share creams or items such as lipsticks etc
– Avoid kissing etc until cold sores have healed
– Use of appropriate therapy to reduce symptoms and
speed healing
– Continued use of skin protectant to keep lesions moist
* Triggers
– Discuss avoidance of potential triggers, use sunscreen
– Antiviral creams do not prevent outbreaks
* Recurrent Episode
– Importance of treatment at first sign or symptom of
recurrence